View all cases
- Case details
- Status—ActionProcedural applicationCategoryOther procedural
- Parties
- Respondents
- Meril GmbHOperating co.
- Meril Life Sciences Pvt Ltd.Operating co.
Representatives- Andreas von Falck-Hogan Lovells International LLP
- Division
- Munich LD
- Technology
- InstrumentsMedical technology
- Language
- —
- First decided
- Mar 5, 2024
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Munich LD | Locked |
| Judge Matthias Zigann | Locked |
| Judge Tobias Pichlmaier | Locked |
| Judge Margot Kokke | Locked |
| Judge Stefan Wilhelm | Locked |
At the UPC: Edwards Lifesciences Group (57 cases)·Meril Group (60 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 20 other proceedings
UPC CoA 166/2025·UPC CoA 21/2025·UPC CoA 27/2025·UPC CFI 815/2024·UPC APP 60159/2024 and 15 more
5 other defendants litigating the same or a related patent
UPC CFI 202/2025·UPC CFI 674/2024·UPC CoA 530/2024·UPC CoA 464/2024·UPC CFI 255/2023
Decisions
- 2024-03-05
Summary: The Munich Local Division denied Edwards Lifesciences Corporation's request to convert a scheduled video-conference intermediate hearing to an in-person hearing, and also denied the court-ordered simultaneous interpretation from German into English, ruling that the claimant had voluntarily chosen German as the language of proceedings and could arrange interpretation at its own expense under R. 109.2 RoP.
Show the legal issues (3)
- In-person versus video-conference hearing format
- Language of proceedings and simultaneous interpretation under R. 109.2 RoP
- Claimant's own choice of language of proceedings
Documents
- 0B4E44E234D044B4027F0109D4C0C502_de.pdf2024-03-05DE